Aciraft-20 Tablets

Aciraft-20 Tablets contain Rabeprazole Sodium IP 20 mg, a well-established proton pump inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the H⁺/K⁺-ATPase enzyme system in the gastric parietal cells. This targeted mechanism helps in effective control of excess acid production and promotes healing of acid-related mucosal damage.

The tablets are gastro-resistant, ensuring that the active ingredient is protected from degradation in the acidic environment of the stomach and is released at the appropriate site for optimal absorption and therapeutic action. This formulation provides long-lasting relief from acidity and associated symptoms.

Aciraft-20 is commonly prescribed in the management of gastro-esophageal reflux disease (GERD), acid peptic disorders, heartburn, hyperacidity, and gastric or duodenal ulcers. Regular use as advised by a physician helps reduce recurrence of symptoms and improves patient comfort.

Composition
Each gastro-resistant tablet contains:
Rabeprazole Sodium IP — 20 mg
Excipients — q.s.

Indications
Gastro-esophageal reflux disease (GERD)
Acid peptic disorder
Heartburn and hyperacidity
Gastric and duodenal ulcers

Key Benefits
Effective and sustained suppression of gastric acid
Helps in healing of acid-induced gastric mucosal injury
Gastro-resistant formulation for improved efficacy
Reduces recurrence of acidity and reflux symptoms

Dosage and Administration
To be taken as directed by the physician. Tablet should be swallowed whole and not chewed or crushed.

Storage
Store below 25°C in a dry place. Protect from light.
Keep out of reach of children.

Regulatory Information
Schedule H prescription drug. To be sold by retail on the prescription of a Registered Medical Practitioner only.